AIHTA - Publications - Search - Ripretinib (Qinlock®) for the treatment of patients with advanced gastrointestinal stromal tumour (GIST)

Wolf, S. (2021): Ripretinib (Qinlock®) for the treatment of patients with advanced gastrointestinal stromal tumour (GIST). Oncology Fact Sheet Nr. 62.

[thumbnail of Oncology Fact Sheet Nr.62.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
96kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WI Digestive system > WI 250 Oesophagus
WI Digestive system > WI 300-387 Stomach
WI Digestive system > WI 400-560 Intestines
WI Digestive system > WI 600-650 Anus. Rectum
Language:English
Series Name:Oncology Fact Sheet Nr. 62
Deposited on:15 Oct 2021 15:15
Last Modified:15 Oct 2021 15:50

Repository Staff Only: item control page